Olopatadine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Olopatadine Hydrochloride
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Olopatadine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 17 USDMF, 9 JDMF, 6 EU WC, 14 KDMF, 14 NDC API, 23 Listed Suppliers, $ API Reference Price

38 API Suppliers
17 USDMF
9 JDMF
6 EU WC
14 KDMF
14 NDC API
23 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

12 Intermediate Suppliers

12 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

85 FDF Dossiers, 35 FDA Orange Book, 13 Europe, 13 Canada, 2 South Africa, 22 Listed Dossiers

85 FDF Dossiers
35 FDA Orange Book
13 Europe
13 Canada
2 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE, SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE
SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE
SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE
SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 DKSH, 2 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 3 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

40 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 19 Controlled & Modified Release, 14 Direct Compression, 12 Taste Masking, 12 Chewable & Orodispersible Aids, 11 Solubilizers, 11 Parenteral, 10 Granulation, 9 Disintegrants & Superdisintegrants, 7 Film Formers & Plasticizers, 7 Co-Processed Excipients, 5 Empty Capsules, 4 Thickeners and Stabilizers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Topical, 2 Coloring Agents, 2 Rheology Modifiers, 1 Emulsifying Agents, 1 Lubricants & Glidants, 1 Surfactant & Foaming Agents

40 Coating Systems & Additives
30 Fillers, Diluents & Binders
19 Controlled & Modified Release
14 Direct Compression
12 Taste Masking
12 Chewable & Orodispersible Aids
11 Solubilizers
11 Parenteral
10 Granulation
9 Disintegrants & Superdisintegrants
7 Film Formers & Plasticizers
7 Co-Processed Excipients
5 Empty Capsules
4 Thickeners and Stabilizers
4 Vegetarian Capsules
4 API Stability Enhancers
3 Topical
2 Coloring Agents
2 Rheology Modifiers
1 Emulsifying Agents
1 Lubricants & Glidants
1 Surfactant & Foaming Agents

DIGITAL CONTENT

48 NEWS #PharmaBuzz

48 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 12 Finished Drug Prices, 17 Annual Reports

2 US Medicaid Prescriptions
12 Finished Drug Prices
17 Annual Reports

MARKET PLACE

18 APIs, 5 FDF Dossiers

18 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 6 Health Canada Patents

17 US Patents
1 US Exclusivities
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 3 Others

1 USP
3 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 5,613 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 4Alcon Canada Inc.

02 2Gowling WLG (Canada) LLP

filter Patent Reset all filters

6 All

01 21337603

02 22195094

03 12447924

04 12826725

filter Product Reset all filters

6 All

01 1OLOPATADINE HYDROCHLORIDE

02 5Olopatadine Hydrochloride

filter Dosage Reset all filters

6 All

01 1SOLUTION

02 5Solution

filter Exp Date Reset all filters

6 All

01 22012-11-21

02 22016-05-03

03 12022-06-19

04 12032-05-18

Seqens Olopatadine Hydrochloride

Product Main Page

01

Alcon Canada Inc.

Olopatadine Hydrochloride

PharmScience R&D

Not Confirmed

Alcon Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-11-21

Date Granted : 1995-11-21

Olopatadine Hydrochloride

Brand Name : PATANOL

Patent Number : 1337603

Filing Date : 1990-08-02

Strength per Unit : 0.1%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic (topical)

Patent Expiration Date : 2012-11-21

Date Granted : 1995-11-21

Portfolio PDF

Product Web Link

Digital Content

02

Alcon Canada Inc.

Olopatadine Hydrochloride

PharmScience R&D

Not Confirmed

Alcon Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-03

Date Granted : 2002-02-26

Olopatadine Hydrochloride

Brand Name : PATANOL

Patent Number : 2195094

Filing Date : 1996-05-03

Strength per Unit : 0.1%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic (topical)

Patent Expiration Date : 2016-05-03

Date Granted : 2002-02-26

Portfolio PDF

Product Web Link

Digital Content

03

Alcon Canada Inc.

Olopatadine Hydrochloride

PharmScience R&D

Not Confirmed

Alcon Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-11-21

Date Granted : 1995-11-21

Olopatadine Hydrochloride

Brand Name : PATADAY

Patent Number : 1337603

Filing Date : 1987-03-03

Strength per Unit : 0.2%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2012-11-21

Date Granted : 1995-11-21

Portfolio PDF

Product Web Link

Digital Content

04

Alcon Canada Inc.

Olopatadine Hydrochloride

PharmScience R&D

Not Confirmed

Alcon Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-05-03

Date Granted : 2002-02-26

Olopatadine Hydrochloride

Brand Name : PATADAY

Patent Number : 2195094

Filing Date : 1996-05-03

Strength per Unit : 0.2%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2016-05-03

Date Granted : 2002-02-26

Portfolio PDF

Product Web Link

Digital Content

05

Gowling WLG (Canada) LLP

Olopatadine Hydrochloride

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-06-19

Date Granted : 2009-11-03

Olopatadine Hydrochloride

Brand Name : PATADAY

Patent Number : 2447924

Filing Date : 2002-06-19

Strength per Unit : 0.2%

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2022-06-19

Date Granted : 2009-11-03

Portfolio PDF

Product Web Link

Digital Content

06

Gowling WLG (Canada) LLP

Olopatadine Hydrochloride

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-18

Date Granted : 2016-11-01

Olopatadine Hydrochloride

Brand Name : PAZEO

Patent Number : 2826725

Filing Date : 2012-05-18

Strength per Unit : 0.7% w / v

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OPHTHALMIC

Patent Expiration Date : 2032-05-18

Date Granted : 2016-11-01

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!